Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
Miguel Á. Sanz(Instituto de Investigación Sanitaria La Fe), Francesco Lo‐Coco(Fondazione Santa Lucia), Pau Montesinos(Instituto de Salud Carlos III), Harry Iland(Royal Prince Alfred Hospital), Giuseppe Avvisati(Università Campus Bio-Medico), Lionel Adès(Délégation Paris 7), Eva Lengfelder, Alan K. Burnett(Cardiff University), Pierre Fenaux(Saint Louis University Hospital), Nigel H. Russell(Guy's and St Thomas' NHS Foundation Trust), Vikram Mathews(Christian Medical College & Hospital), Eduardo Magalhães Rego(Universidade de São Paulo), Bob Löwenberg(Unknown), Elihu H. Estey(University of Washington), Uwe Platzbecker(National Center for Tumor Diseases), Hartmut Döhner(University Hospital Ulm), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center), Sai-Juan Chen(Shanghai Jiao Tong University), Farhad Ravandi(The University of Texas MD Anderson Cancer Center), Tomoki Naoe(National Hospital Organization), Martin S. Tallman(Memorial Sloan Kettering Cancer Center)
Cited by 655
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k